From the Research
Alcohol sclerosing injections are a viable treatment option for Morton's neuroma, with a success rate of over 82% per single injection, as demonstrated in the most recent and highest quality study 1. The procedure involves injecting a solution of 70% ethanol, as shown to be effective in the study 1, mixed with a local anesthetic directly into the affected intermetatarsal space. Some key points to consider when using alcohol sclerosing injections for Morton's neuroma include:
- The use of fluoroscopic and electroneurographic guidance to ensure accurate placement of the injection, as described in the study 1
- The potential for significant improvement in pain scores, with a "success rate" of more than 82% per single injection, as reported in the study 1
- The possibility of mild pain persisting in some patients who participate in sports, as noted in the study 1
- The importance of using a higher percentage of ethanol, such as 70%, and a higher dosage, such as 2.5 mL, as shown to be effective in the study 1 It is also important to consider the findings of other studies, such as the one published in 2020 2, which reported a success rate of 71.2% with percutaneous alcoholization of Morton's neuroma with phenol by electrostimulation guidance. However, the most recent and highest quality study 1 provides the strongest evidence for the effectiveness of alcohol sclerosing injections in treating Morton's neuroma. Overall, alcohol sclerosing injections can be a safe and effective treatment option for Morton's neuroma, with a high success rate and minimal side effects, as demonstrated in the study 1.